Кити оптимістично налаштовані на XRP, незважаючи на спад, тоді як конкурент Injective показує зростання. 17.02.2024 Кити оптимістично налаштовані на XRP, незважаючи на спад, тоді як конкурент Injective показує зростання. 17.02.2024
Кити оптимістично налаштовані на XRP, незважаючи на спад, тоді як конкурент Injective показує зростання. 17.02.2024
17 лютого 2024
Кити оптимістично налаштовані на XRP, незважаючи на спад, тоді як конкурент Injective показує зростання. 17.02.2024

Кити оптимістично налаштовані на XRP, незважаючи на спад, тоді як конкурент Injective показує зростання. 17.02.2024

Стаття:
Whales Bullish on XRP Despite Dip, While Injective Rival Shows Growth

XRP whales are accumulating the digital asset despite the recent price dip. Meanwhile, Injective Protocol's native token, INJ, has seen a significant surge in its price.

XRP Whales Accumulate Despite Price Dip

Despite the recent dip in XRP's price, large holders of the digital asset, known as whales, have been accumulating more tokens. This suggests that these large investors are bullish on the future prospects of XRP and are taking advantage of the lower prices to increase their holdings.

According to data from Santiment, the number of addresses holding at least 1,000,000 XRP has increased by 3.7% in the past two weeks. This indicates that whales are confident in XRP's long-term potential and are willing to bet on its future success.

Injective Protocol's INJ Sees Price Surge

While XRP has been facing a price dip, Injective Protocol's native token, INJ, has been experiencing a significant surge in its price. The token's price has more than doubled in the past week, reaching an all-time high of $13.80.

This surge in price can be attributed to the growing popularity of decentralized finance (DeFi) and the increasing adoption of the Injective Protocol. The platform allows users to trade a wide range of assets, including cryptocurrencies, stocks, and forex, in a decentralized and permissionless manner.

As a result, the demand for INJ has been increasing, driving up its price and market capitalization. This growth in the token's value indicates that investors are optimistic about the future prospects of the Injective Protocol and are willing to bet on its success.